Canopy Growth is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. 

From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across four continents. 

Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using a colour-coded classification Spectrum system. 

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships. 

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. 

Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. 

Canopy Growth operates eleven licensed cannabis production sites with over 7.5 million square feet of production capacity, including over one million square feet of GMP certified production space.

Canopy Growth

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

McGill University : Associate Professor

Vice Chair, Federal Task Force on the Legalization and Regulation of Cannabis in Canada

Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society

Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus

Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function

Smoked cannabis for chronic neuropathic pain: a randomized controlled trial

Pharmacological management of chronic neuropathic pain–consensus statement and guidelines from the Canadian Pain Society

Dr. Ware is Canopy Growth’s Chief Medical Officer and leads its medical division, Spectrum Therapeutics. Activities that Dr. Ware oversees include the production and distribution of full-spectrum and single cannabinoid medical cannabis products; industry-leading education, resources and support for patients and healthcare practitioners; and pre-clinical and clinical research including the development of validated cannabinoid-based medicines.

Before joining Canopy in July 2018, Dr. Ware spent over 20 years researching and evaluating different uses for medical cannabis. 

He is an Associate Professor in Family Medicine and Anesthesia at McGill University and over the past 10 years he has served as the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre, and Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids. 

A family physician by training, Dr. Ware continues to practice pain medicine at the Montreal General Hospital and at a public interdisciplinary primary care pain clinic he established on the West Island of Montreal. His research has focused on the safety, efficacy and effectiveness of cannabis and cannabinoids in pain and symptom management. 

Dr. Ware is a graduate of the University of the West Indies, and worked at the MRC Sickle Cell Unit in Kingston, Jamaica from 1996-1998 where he developed his interests in pain management and cannabis therapeutics. He moved to McGill University to begin his program of cannabis research in 1999. 

Dr. Ware has acted as an advisor on medical cannabis policy to the Canadian government since 2001, and served as Vice Chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada in 2016.

Endocannabinoid System

Cannabis Research

Cannabinoids

Medical Cannabis

Clinical Research

Google Scholar Citations

Vice-chair of task force on legalizing pot takes lead research post with Canopy Growth

Seniors study aims to find out if medical cannabis can ease common ailments of aging

Doctors call for more education when it comes to prescribing cannabis

Legalization sparks boom in once-stigmatized field of marijuana research

Chief Medical Officer

Dr. Mark Ware, Chief Medical Officer at Canopy Growth, speaks to NewsPoint360 about how the stigma of cannabis consumption has evolved over the last hundred years, and how popular opinion has changed over the years in terms of its potential risks and benefits.

Learn more about Dr. Ware's expertise and media appearances here:  https://expertfile.com/experts/drmark.ware

NewsPoint360 is a news organization focused on giving credible experts a platform through video interviews that are uniquely designed for media and other key audiences looking for knowledgeable perspectives on trending stories.

Visit other NewsPoint360 channels:
Website: https://newspoint360.net/
Twitter: http://np360media.net/Twitter
LinkedIn: http://np360media.net/LinkedIn
YouTube: http://np360media.net/YouTube

Dr. Mark Ware on Cannabis Stigma

In this video, Dr Mark Ware, talks to Medical Marijuana 411 about pain, pain management and how cannabis can have a positive impact on those inflicted with pain issues. 

Dr Mark Ware is one of the featured medical professionals in the Medical Marijuana 411 online education courses for medical professionals, patients and dispensary technicians. This is an example of the video content that is part of the online education. With more thank 800 peer reviewed citations, downloadable graphics, Medical Marijuana 411 is the leader in cannabis education. Check out the entire list of certifications and courses offered at http://www.medicalmarijuana411.com

Medical Marijuana 411 Talks With Dr Mark Ware

2017 Departmental Day - Cannabis in Canada: What do we know? What can we expect?

McGill University department of psychiatry.

Cannabis in Canada -  Dr.  Mark A  Ware, MBBS MSc

Select Inquiry Type